Literature DB >> 15233872

Cardioprotective effect of tincture of Crataegus on isoproterenol-induced myocardial infarction in rats.

R Jayalakshmi1, S Niranjali Devaraj.   

Abstract

Tincture of Crataegus (TCR), an alcoholic extract of the berries of hawthorn (Crataegus oxycantha), is used in herbal and homeopathic medicine. The present study was done to investigate the protective effect of TCR on experimentally induced myocardial infarction in rats. Pretreatment of TCR, at a dose of 0.5 mL/100 g bodyweight per day, orally for 30 days, prevented the increase in lipid peroxidation and activity of marker enzymes observed in isoproterenol-induced rats (85 mg kg(-1) s. c. for 2 days at an interval of 24 h). TCR prevented the isoproterenol-induced decrease in antioxidant enzymes in the heart and increased the rate of ADP-stimulated oxygen uptake and respiratory coupling ratio. TCR protected against pathological changes induced by isoproterenol in rat heart. The results show that pretreatment with TCR may be useful in preventing the damage induced by isoproterenol in rat heart.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15233872     DOI: 10.1211/0022357023745

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

1.  Pretreatment with alcoholic extract of Crataegus oxycantha (AEC) activates mitochondrial protection during isoproterenol - induced myocardial infarction in rats.

Authors:  R Jayalakshmi; C J Thirupurasundari; S Niranjali Devaraj
Journal:  Mol Cell Biochem       Date:  2006-05-30       Impact factor: 3.396

2.  Cardioprotective properties of Crataegus oxycantha extract against ischemia-reperfusion injury.

Authors:  J K Swaminathan; M Khan; I K Mohan; K Selvendiran; S Niranjali Devaraj; B K Rivera; P Kuppusamy
Journal:  Phytomedicine       Date:  2010-02-18       Impact factor: 5.340

3.  Anti-inflammatory and anti-apoptotic effects of Crataegus oxyacantha on isoproterenol-induced myocardial damage.

Authors:  Navin Alukkathara Vijayan; Mohana Thiruchenduran; Sivasitamparam Niranjali Devaraj
Journal:  Mol Cell Biochem       Date:  2012-02-15       Impact factor: 3.396

4.  Ethnoveterinary medicines used for horses in Trinidad and in British Columbia, Canada.

Authors:  Cheryl Lans; Nancy Turner; Gerhard Brauer; Grant Lourenco; Karla Georges
Journal:  J Ethnobiol Ethnomed       Date:  2006-08-07       Impact factor: 2.733

Review 5.  Effect of crataegus usage in cardiovascular disease prevention: an evidence-based approach.

Authors:  Jie Wang; Xingjiang Xiong; Bo Feng
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-29       Impact factor: 2.629

6.  Extracts of Crataegus oxyacantha and Rosmarinus officinalis Attenuate Ischemic Myocardial Damage by Decreasing Oxidative Stress and Regulating the Production of Cardiac Vasoactive Agents.

Authors:  Raúl Enrique Cuevas-Durán; Juan Carlos Medrano-Rodríguez; María Sánchez-Aguilar; Elizabeth Soria-Castro; María Esther Rubio-Ruíz; Leonardo Del Valle-Mondragón; Alicia Sánchez-Mendoza; Juan Carlos Torres-Narvaéz; Gustavo Pastelín-Hernández; Luz Ibarra-Lara
Journal:  Int J Mol Sci       Date:  2017-11-14       Impact factor: 5.923

7.  Protective effects of Hawthorn (Crataegus oxyacantha) extract against digoxin-induced arrhythmias in rats.

Authors:  Hayrullah Alp; Burak Cem Soner; Tamer Baysal; Ayşe Saide Şahin
Journal:  Anatol J Cardiol       Date:  2014-12-25       Impact factor: 1.596

Review 8.  Botanical, Phytochemical, Anti-Microbial and Pharmaceutical Characteristics of Hawthorn (Crataegusmonogyna Jacq.), Rosaceae.

Authors:  Federico Martinelli; Anna Perrone; Sanaz Yousefi; Alessio Papini; Stefano Castiglione; Francesco Guarino; Angela Cicatelli; Mitra Aelaei; Neda Arad; Mansour Gholami; Seyed Alireza Salami
Journal:  Molecules       Date:  2021-11-30       Impact factor: 4.411

9.  Crataegus aronia enhances sperm parameters and preserves testicular architecture in both control and non-alcoholic fatty liver disease-induced rats.

Authors:  Mohammad Dallak
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.